Together with the EIB, five of the EU’s largest national promotional banks and institutions plan to invest...
Up To Date
Latest News
Danish cancer antibody powerhouse Genmab plans to raise US$505m in its US IPO. The money will go towards its...
Dutch biopharma company AM-Pharma B.V. has secured €116m to bring its acute kidney injury treatment into Phase...
Belgian biotech Galapagos NV has entered into a R&D collaboration with Gilead Sciences. The US drug maker is...
German pharma major Boehringer Ingelheim has taken over Swiss cancer immunotherapy player AMAL Therapeutics.
French microalgae specialist Microphyt has raised €28.5m to develop its microalgae portfolio for nutrition and...
Share
